Skip to main content
. 2012 Jul 19;2012:541842. doi: 10.1155/2012/541842

Table 2.

Survival rates in HYPERO study. Adapted from [87].

Time-point HIPEC used n OS (m) 2 years % 5 years %
Overall 141 30.3 49.1 25.4
Frontline 26 41.7 57.0 33.3
Interval debulking 19 68.6 80.4 50.2
Consolidation 12 53.7 63.6 42.4
Recurrence 83 23.5 40.9 18.0

OS: overall survival.